Neoplasia/BPH

	[Hereditary leiomyomatosis and renal cell carcinoma syndrome : Pathological features, diagnostics, and clinical implications]. Pathologie (Heidelb) Erber R, Hartmann A. PMID: 42521857 [PubMed - as supplied by publisher]
	Telomere stability pathway genes as predictors of susceptibility and prognosis in urothelial bladder cancer: review and bioinformatics analyses. J Toxicol Environ Health B Crit Rev da Silva IM, Rocha LMO, de Andrade QG, de Lima LVA, Vacario BGL, de Almeida TM, Maraslis FT, Martinez-López W, Debia N, de Sousa AA, de Castro E Sousa JM, Serpeloni JM. PMID: 42521654 [PubMed - as supplied by publisher]
	Influence of Adverse Pathologic Features on Potential Benefit of Hormone Therapy Use with Postoperative Radiotherapy in Recurrent Prostate Cancer: An Individual Patient Data Meta-analysis. Eur Urol Kishan AU, Sun Y, Parker CC, Sargos P, Sydes M, Chabaud S, Brihoum M, Supiot S, Latorzeff I, Guerif S, Kalbasi TR, Steinberg ML, Valle LF, Taparra K, Farrell MJ, Shoag JE, Garcia JA, Brown JR, Rettig MB, Singer AE, Baclig N, Reiter RE, Eggener S, Brisbane W, Roy S, Jia AY, Ma TM, Nickols NG, Efstathiou JA, Dignam JJ, Seiferheld WF, Pollack A, Sandler HM, Nguyen PL, Pommier P, Spratt DE. PMID: 42521517 [PubMed - as supplied by publisher]
	Assessing the Feasibility of a Self-Management Intervention for Individuals With Advanced Prostate Cancer and Comorbid Type II Diabetes Mellitus. Cancer Med Shaver AL, Steinbock-Malfer C, Tester W, Mille P, Kelly WK, Zarrabi KK, Lallas CD, Shah M, DiMarco R, Brand E, Brown S, Sharma S, Nikita N, Cogen C, Keith SW, Lu-Yao G. PMID: 42521319 [PubMed - as supplied by publisher]
	Squamous Cell Carcinoma of the Bladder: Current Evidence, Therapeutic Challenges, and Research Perspectives from the French AVENTUR Group. Crit Rev Oncol Hematol Mercier J, Cornillon P, Barthélémy P, Leon P, Fontugne J, Guimas V, Bouleftour W, Olivier L, Affi R, Pouessel D, Culine S, Roumiguié M, Mahammedi H, Thibault C, Moinard-Butot F. PMID: 42520864 [PubMed - as supplied by publisher]
	Perioperative Immunotherapy in Muscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Neoadjuvant and Adjuvant Strategies. Clin Oncol (R Coll Radiol) Suartz CV, Huber IMT, Brito PHS, de Lima RD, Freitas APS, de Almeida LS, Liebl B, Reis GBB, Sant'Anna PVH, de Campos VDF, Mota JM, Reis LO, Nahas WC, Dener MC, Shahrour W, Shabana W, Ribeiro-Filho LA. PMID: 42520756 [PubMed - as supplied by publisher]
	Carbonic anhydrase IX-targeted small molecule radiopharmaceuticals: A review of their role in clear cell renal cell carcinoma theranostics. Nucl Med Biol Liu Y, Zhang M, Ge X, Meng X. PMID: 42520690 [PubMed - as supplied by publisher]
	Urinary biomarkers in muscle-invasive bladder cancer: Current state and open opportunities for neoadjuvant chemotherapy response prediction and patient stratification. Biomed Pharmacother de Miguel-García G, Ruiz de Porras V, Font-Morón M, Font A, Borràs FE, Clos-Sansalvador M. PMID: 42520639 [PubMed - as supplied by publisher]
	Comparison of biparametric and multiparametric prostate MRI to assess extraprostatic tumor extension. Eur J Radiol Bischoff LM, Schmidt CJ, Endler C, Bernhardt M, Kristiansen G, Ellinger J, Hauser S, Ohlmann CH, Luetkens JA, Ritter M, Mesropyan N, Krausewitz P, Isaak A. PMID: 42520381 [PubMed - as supplied by publisher]
	Impact of PSMA PET Staging on Initial Treatment in Newly Diagnosed Prostate Cancer. J Nucl Med Miller SR, Chung DH, Gonzalez RT, Jackson WC, Caram MEV, Tsao PA, Stensland K, Gulati R, Shah Y, Wale D, Elliott D, Caverly T, Hofer TP, Saini S, Green MD, Schipper M, Dess RT, Bryant AK. PMID: 42520266 [PubMed - as supplied by publisher]
	Early outcomes after focal high-dose-rate brachytherapy in low- and favorable intermediate-risk prostate cancer: promising early results from a prospective randomized trial. Open Med (Wars) Jonusas J, Patasius A, Trakymas M, Akelaitis K, Dziugelis M, Burkanas M, Venius J, Smailyte G, Kincius M. PMID: 42519814 [PubMed - as supplied by publisher]
	Research progress in metabolic reprogramming and targeting metabolic pathways for clear cell renal cell carcinoma. Genes Dis Yao JT, Hu PC, Li XW, Xu JC, Wang KJ, Ye SZ, Meng XY, Chen HC, Liang Y, Ma Q. PMID: 42519728 [PubMed - as supplied by publisher]
	Real-world implementation of a pre-consultation patient educational tool for intermediate risk prostate cancer. Clin Transl Radiat Oncol Borras-Osorio M, Kowalchuk RO, Preston HR, Rajkumar AW, Uptmor AM, Davis BJ, Choo CR, Stish BJ, Phillips RM, Malouff TD, Traughber BJ, Wilson J, Lozko Y, Mastroleo F, Namazi MJ, Routman DM, Ebner DK, Waddle MR. PMID: 42519504 [PubMed - as supplied by publisher]
	Diagnostic and Clinicopathological Utility of High-Molecular-Weight Cytokeratin (HMWCK) and NKX3.1 Immunohistochemistry in Prostatic Adenocarcinoma. Cureus Singh A, Imam ZS, Kumari M, Kumar B, Ranjan N. PMID: 42519281 [PubMed - as supplied by publisher]
	Factors associated with help-seeking for urinary symptoms among Chinese patients with bladder cancer: A qualitative study. Asia Pac J Oncol Nurs Wang B, Zou J, Gao L, Lou F, Qi Z, Dai Y. PMID: 42519177 [PubMed - as supplied by publisher]
	Incremental diagnostic value of MRI PI-RADS classification combined with PSA density for prostate cancer. Front Oncol Sun X, Chen Y, Ling S, Gong S, Liu B. PMID: 42518805 [PubMed - as supplied by publisher]
	Perioperative therapy in muscle-invasive bladder cancer: real-world evidence from the MINOTAURO study. ESMO Real World Data Digit Oncol Lainez N, Martínez-Kareaga M, Sagastibeltza-Marinalarena N, Sánchez M, Díaz de Cerio A, Sánchez-Escribano R, Sotelo M, Torre S, Calderero V, Verdún JA, Gil-Arnáiz I, Menéndez M, Moreno A, de Ávila L, Fernández R, Trincado P, Peláez M, Anido U, Climent MÁ, Durán I. PMID: 42518717 [PubMed - as supplied by publisher]
	Comparative Evaluation of AI Chatbots for Testicular Cancer Education: Validity, Information Quality, and Readability. Ann Surg Oncol Zhao J, Sun S, Zhao A, Liang R, Peng L, Peng X, Li R. PMID: 42518148 [PubMed - as supplied by publisher]
	Surgical Management of PSMA PET-Positive Lymph Nodes in Prostate Cancer. Curr Urol Rep Cosenza A, Quarta L, Galdieri A, Brancaccio M, Occhi A, Porzi ME, Zaurito P, Viti A, Santangelo A, Scilipoti P, Scuderi S, Barletta F, Stabile A, Montorsi F, Briganti A, Gandaglia G. PMID: 42518100 [PubMed - as supplied by publisher]
	Impact of central review and MRI image quality on prostate cancer diagnosis and biopsy decision-making in referred patients. Abdom Radiol (NY) Zheng Z, Liu Y, Wu S, Chen Y, Jin P, Shi L, Zhang G, Sun H, Wang X, Xu L. PMID: 42517901 [PubMed - as supplied by publisher]

Articles 1 - 20 / 190082

Page 1 of 9505



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy